Kartik Jhaveri1, Stephan Kannengiesser2, Nima Sadougi3, Marshall Sussman1, Hooman Hosseini-Nik3, Leila Zahedi3, and Richard Ward1
1UHN,University of Toronto, Toronto, ON, Canada, 2Siemens Germany, Erlangen, Germany, 3UHN, Toronto, ON, Canada
Synopsis
MRI is currently utilised as a non-invasive
method for liver iron concentration (LIC) estimation and has essentially
replaced liver biopsy. FerriScan derived LIC is considered the “gold standard”
but has associated increased costs and delay results from required external
data transmittal. There is no universal agreement or standardization of R2*
derived LIC methods. We describe an optimized R2* method with noise corrected post
processing of data for LIC estimation with simultaneous comparison to FerriScan
derived LIC. Our results show very good correlation between R2* LIC and FerriScan
LIC with potential for substitution of the latter with our R2* technique. Background
Patients
with liver iron overload require frequent assessment of
liver iron concentration (LIC) for therapy monitoring and complication risks
ideally by non-invasive methods.FerriScan
(Resonance Health, Claremont, WA, Australia is) is
a well-established MRI technique for LIC estimation but adds costs and need for
external data transmittal for procurement of results
(1, 2). R2* based LIC estimations have been reported previously (3-5) however these are not
standardised as the acquisition parameters,data post processing and conversion formulae are variable.
Recently, Garbowski et al (6) have reported biopsy based calibration of a T2*
method for LIC calculation and comparison to FerriScan.
Purpose
To compare prospectively and intra-individually R2*derived LIC
with noise-corrected post processing of data against
FerriSscan
reported LIC obtained on the same day.
Methods
127 patients
(70 women, 57 men) with a mean age of 38 years (range, 19-72) prospectively underwent
FerriScan and R2* MR imaging on the same day. Thalassemia was the most common diagnosis ( 82.7%). 80 %( 105/127) had history of blood
transfusion, and 36% (48/127) had undergone splenectomy. Hemoglobin and
ferritin levels were available in 118 patients, in which 90% (106/108) were
anemic (Hb <120 g/l). The mean serum hemoglobin and ferritin were 101 g/L
(range, 57-147 g/L) and 2040 ng/ml (range, 8-14094 ng/L) respectively.
MRI
was performed on all on 1.5T (MAGNETOM Aera, Siemens Healthcare, Erlangen,Germany).FerriScan
acquisition using free breathing multi-spinecho sequence was as per mandated
protocol. An optimised prototype 3D 6 echo breathhold gradient echo acquisition with lowest TE
of ~1ms with TE range 1-9ms, constant TR 11.8ms
was acquired immediately thereafter.(Fig.1)For each subject, the
individual gradient-echo magnitude images were saved in DICOM format, and
re-imported in Matlab (The MathWorks, Natick, MA, USA). Image pixels were
fitted individually to a signal model containing R2* and optionally fat signal
fraction (FF), as well as a Rician noise signal contribution as described in
(7). A version of equation 3 (7) was used to predict the maximum likelihood
(ML), i.e. the maximum of the probability density function, of the measured
signal s.
Two alternative signal models were used: $$s
= ML(|m_0 \cdot exp(-R_2^* \cdot TE)| \quad \text{given} \, n \quad
\text{(2a)}$$ and R2*-plus-FF (fat signal fraction)
$$s
= ML(|m_0 \cdot ((1-FF) + c(TE) \cdot FF) \cdot exp(-R_2^* \cdot TE)| \quad \text{given}
\, n \quad \text{(2b)}$$ where n is the noise level, and c(TE) are the complex fat
signal dephasing factors. The function lsqcurvefit of Matlab R2012b was used
for parameter fitting, with bounds of [0 inf] on all parameters, and otherwise
standard settings, in particular using the "trust-region-reflective"
algorithm.
Manual ROIs were drawn in a homogeneous region of the right
liver hemisphere. In a firstROI, each pixel was fitted individually to equation
2a and/or 2b with n as a free parameter. The average value of n across the ROI
was taken as n0, excluding pixels for which the parameter fit failed (R2* = 0,
or FF >= 50%). n=n0 as a fixed parameter was then used for fitting all
pixels individually to equation 2, assuming a constant noise level across the
liver. Inaccuracies in the value of n0 were deemed more acceptable than an
increased parameter standard deviation potentially caused by the additional
free model parameter.LIC values were derived from average R2* values in 3
additional ROIs drawn on post-processed data utilizing the equation published
by Garbowski et al (6). LIC derived by R2* and FerriScan were compared using Pearson’s
correlation, linear regression analysis and Bland-Altman plots.
Results
Mean LIC, in mg Fe per g dry weight, derived by FerriScan was 9.7mg/g (Range 0.6-42, median 6.5), by R2* 9.2mg/g (range 0.9-36.9, median 6.8) and by R2*-plus- FF of 9.4(range 0.9-60.5, median 6.3). Comparing R2* -only LIC versus FerriScan, r2=0.9172, Pearson correlation 0.9577(95% CI: 0.9403, 0.9701) with Bland-Altman plots displaying mean difference =1.157(95% CI: -5.603, 7.906) were obtained(Fig.2,3). Comparing R2*plus-FF derived LIC against FerriScan LIC, r2=0.8423, Pearson correlation 0.9178(95% CI: 0.8763, 0.9457) with Bland-Altman plots displaying mean difference =1.283(95% CI: -7.507, 10.07) were obtained. Comparing R2* LIC against R2*-plus-FF LIC r2=0.9397, Pearson correlation 0.9694(95% CI: 0.9533, 0.9800) with Bland-Altman plots displaying mean difference =-0.0597(95% CI: -4.138, 4.018) were obtained.
Conclusion
R2*-derived
LIC with pixel-wise, noise-corrected offline processing provides very good
correlation with FerriScan-derived LIC. Compared with FerriScan, the fit-first
followed by ROI-average of R2* strategy used in this work gives similar results
and better r2 (>0.84) as the reverse order of operations and use of a
truncation model published previously by Garbowski et al (r2=0.65).
Acknowledgements
Gerald R. Moran, Ph.D.Research Collaboration ManagerSiemens Healthcare Limited
Ravi Menezes, PhD, JDMI,University of Toronto.(Statistical Analysis)
References
1. St Pierre TG, Clark PR, Chua-anusorn
W, Fleming AJ, Jeffrey GP, Olynyk JK,Pootrakul P, Robins E, Lindeman R. Noninvasive measurement
and imaging of liver iron
concentrations using proton magnetic resonance. Blood. 2005; 105:855–61.
2. http://www.resonancehealth.com/products/ferriscan-mri-measurement-of-liver-iron-concentration.html
3. Anderson LJ, Holden S, Davis B,
Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM,
Pennell DJ. Cardiovascular
T2-star (T2*)
magnetic
resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001; 22:2171–79.
4. Wood JC, Enriquez C, Ghugre N,
Tyzka JM, Carson S, Nelson MD, Coates TD. MRI R2 and R2* mapping accurately
estimates hepatic iron
concentration
in transfusion-dependent thalassemia and sickle cell
disease patients. Blood. 2005; 106:1460–65.
5. Hankins JS, McCarville MB,
Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, Li CS, Wang WC, Ware RE,
Hillenbrand CM. R2*
magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009; 113:4853–55.
6.Garbowski MW, Carpenter JP, Smith G, Roughton M, Alam MH, He TG, Pennell
DJ, Porter JB. Biopsy-based calibration of T2*magnetic resonance for estimation
of liver iron concentration and comparison with R2 Ferriscan. J Cardiov Magn
Reson 2014;16.
7.Feng Y, He T, Gatehouse PD, Li X, Harith Alam M, Pennell
DJ, Chen W, Firmin DN. Improved MRI R2 * relaxometry of iron-loaded liver with
noise correction. Magn Reson Med. 2013 Dec;70(6):1765-74.